Immunohistochemical Expression of p53 and Bcl-2 in Algerian Cervical Carcinoma
Open Access
- 25 March 2018
- journal article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 11 (1), 67-75
- https://doi.org/10.13005/bpj/1348
Abstract
The Objective of the present study is to evaluate the expression levels of Bcl-2 and p53 proteins in squamous cell carcinoma and adenocarcinoma of the uterine cervix, and try to explain their role as prognostic markers for this cancer. The cohort comprised 90 cases of the cervix lesions. The samples were assessed by immunohistochemistry for the expression of Bcl-2 and p53 proteins. The results showed that the Bcl-2 expression was either absent, low or moderate respectively in 38.96%; 50.65% and 10.39% of SCC cases. However, it was absent or expressed in 76.92% and 23.08% of adenocarcinoma cases respectively. The p53 protein was absent or present respectively in 75.32% and 24.68% of SCC cases as demonstrated by immunohistochemistry. p53 was almost absent in adenocarcinoma samples where only 7.70% of cases were positive. There was no significant correlation between Bcl-2 and p53 expression (p=0.352). We conclude that p53 expression, detected by immunohistochemistry, does not appear to be a prognostic marker for cervical cancer. Nevertheless, Bcl-2 expression seems to provide more information for this disease. It may represent an important indicator for cervical cancer.Keywords
This publication has 38 references indexed in Scilit:
- Expression of Fas Ligand and bcl-2 in Cervical Carcinoma and Their Prognostic SignificanceAmerican Journal of Clinical Pathology, 2005
- Immunocytochemical Expression of p16INK4A and Ki-67 in Cytologically Negative and Equivocal Pap Smears Positive for Oncogenic Human PapillomavirusInternational Journal of Gynecological Pathology, 2005
- Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapyGynecologic Oncology, 2004
- Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1998
- Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.Sexually Transmitted Infections, 1997
- Bcl‐2 protooncogene expression in cervical carcinoma cell lines containing inactive p53Journal of Cellular Biochemistry, 1995
- The p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis : William P. Bennett, Xin Wang, Monica Hollstein∗, Stefan Ambs, Emanuela Felley-Bosco, Kathy Forrester, Marc Greenblatt and Curtis C. Harris. Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892 USA and Unit of Environmental Carcinogenesis and Host Factors, W.H.O., IARC, Lyon, FranceLung Cancer, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984